126 related articles for article (PubMed ID: 1671058)
1. Evaluation of a new 2-nitroimidazole nucleoside analogue, RK-28 as a radiosensitizer for clinical use.
Shibamoto Y; Sasai K; Sakaguchi M; Tamulevicius P; Kitakabu Y; Streffer C; Abe M
Int J Radiat Biol; 1991 Jan; 59(1):105-15. PubMed ID: 1671058
[TBL] [Abstract][Full Text] [Related]
2. [Radiosensitizer: hypoxic cell radiosensitizer].
Mori T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001
[TBL] [Abstract][Full Text] [Related]
3. [Present status of radiation sensitizers--hypoxic cell radiosensitizer].
Murayama C; Mori T
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2135-41. PubMed ID: 2660744
[TBL] [Abstract][Full Text] [Related]
4. KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics.
Sasai K; Shibamoto Y; Takahashi M; Zhou L; Hori H; Nagasawa H; Shibata T; Inayama S; Abe M
Cancer Chemother Pharmacol; 1990; 26(2):112-6. PubMed ID: 2140730
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
Murayama C; Suzuki A; Suzuki T; Miyata Y; Sakaguchi M; Tanabe Y; Tanaka N; Mori T
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
[TBL] [Abstract][Full Text] [Related]
6. Azomycin riboside: a new radiosensitizer.
Pedersen JE; Barron G; Chapman JD
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):415-8. PubMed ID: 7107360
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of various types of new hypoxic cell sensitizers using the EMT6 single cell-spheroid-solid tumour system.
Shibamoto Y; Nishimoto S; Mi F; Sasai K; Kagiya T; Abe M
Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Sep; 52(3):347-57. PubMed ID: 3497891
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers.
Nagasawa H; Bando M; Hori H; Satoh T; Tada T; Onoyama Y; Inayama S
Int J Radiat Oncol Biol Phys; 1992; 22(3):561-4. PubMed ID: 1735696
[TBL] [Abstract][Full Text] [Related]
9. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170.
Sasai K; Shibamoto Y; Takahashi M; Abe M; Wang J; Zhou L; Nishimoto S; Kagiya T
Jpn J Cancer Res; 1989 Nov; 80(11):1113-8. PubMed ID: 2532634
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials of radiosensitizers: what should we expect?
Brown JM
Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):425-9. PubMed ID: 6231272
[TBL] [Abstract][Full Text] [Related]
11. [Radiosensitizing effects of new 2-nitroimidazole nucleoside analogues (RK-28, RK-29)].
Shibamoto Y; Sasai K; Takahashi M; Abe M; Mi FS; Nishimoto S; Kagiya T
Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):13-8. PubMed ID: 3379329
[No Abstract] [Full Text] [Related]
12. Pharmacokinetics of intratumoral RK-28, a new hypoxic radiosensitizer.
Sasai K; Shibamoto Y; Manabe T; Baba N; Takahashi M; Sakaguchi M; Abe M
Int J Radiat Oncol Biol Phys; 1992; 24(5):959-63. PubMed ID: 1447037
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).
Murayama C; Suzuki A; Sato C; Tanabe Y; Shoji T; Miyata Y; Nishio A; Suzuki T; Sakaguchi M; Mori T
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):433-43. PubMed ID: 8514541
[TBL] [Abstract][Full Text] [Related]
14. [Development of new hypoxic cell radiosensitizer in Japan].
Mori T; Murayama C
Gan No Rinsho; 1988 Oct; 34(13):1869-74. PubMed ID: 2974089
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
Agrawal KC; Rupp WD; Rockwell S
Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
[TBL] [Abstract][Full Text] [Related]
16. [Radiosensitization by hypoxic cell radiosensitizer--present status of radiosensitizer].
Murayama C; Mori T
Gan No Rinsho; 1990 Oct; 36(13):2249-54. PubMed ID: 2147449
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of suppositories for RK-28 (a new radiosensitizer) using rabbits.
Kim NS; Umejima H; Miyata K; Okubo M; Goto S; Kato T; Mikami Y; Sagitani H; Inoue H
Biol Pharm Bull; 1994 May; 17(5):672-5. PubMed ID: 7920431
[TBL] [Abstract][Full Text] [Related]
18. [Radiosensitizing effect of new hypoxic cell radiosensitizer, RK-28 on experimental animal normal tissue and Ehrlich tumor].
Miyamato Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Aug; 45(8):1142-51. PubMed ID: 3841586
[No Abstract] [Full Text] [Related]
19. In vivo radiosensitizing effect of nitroimidazole derivative KIN-804.
Tada T; Nakajima T; Onoyama Y; Murayama C; Mori T; Nagasawa H; Hori H; Inayama S
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):601-5. PubMed ID: 8005823
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
Brown DM; Dionet C; Brown JM
Radiat Res; 1984 Jan; 97(1):162-70. PubMed ID: 6229806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
